Assuntos
Fator VIII/uso terapêutico , Hemartrose/prevenção & controle , Hemofilia A/tratamento farmacológico , Articulações/efeitos dos fármacos , Pré-Escolar , Estudos de Coortes , Fator VIII/história , Feminino , Hemartrose/sangue , Hemartrose/mortalidade , Hemartrose/patologia , Hemofilia A/sangue , Hemofilia A/mortalidade , Hemofilia A/patologia , História do Século XX , História do Século XXI , Humanos , Lactente , Injeções Intravenosas , Articulações/irrigação sanguínea , Articulações/patologia , Masculino , Análise de Sobrevida , Tempo para o TratamentoRESUMO
OBJECTIVE: The extent that inherited bleeding disorders affect; number, size and location of bruises in young children <6â years. DESIGN: Prospective, longitudinal, observational study. SETTING: Community. PATIENTS: 105 children with bleeding disorders, were compared with 328 without a bleeding disorder and classified by mobility: premobile (non-rolling/rolling over/sitting), early mobile (crawling/cruising) and walking and by disease severity: severe bleeding disorder factor VIII/IX/XI <1â IU/dL or type 3 von Willebrand disease. INTERVENTIONS: Number, size and location of bruises recorded in each child weekly for up to 12â weeks. OUTCOMES: The interventions were compared between children with severe and mild/moderate bleeding disorders and those without bleeding disorders. Multiple collections for individual children were analysed by multilevel modelling. RESULTS: Children with bleeding disorders had more and larger bruises, especially when premobile. Compared with premobile children without a bleeding disorder; the modelled ratio of means (95% CI) for number of bruises/collection was 31.82 (8.39 to 65.42) for severe bleeding disorders and 5.15 (1.23 to 11.17) for mild/moderate, and was 1.81 (1.13 to 2.23) for size of bruises. Children with bleeding disorders rarely had bruises on the ears, neck, cheeks, eyes or genitalia. CONCLUSIONS: Children with bleeding disorder have more and larger bruises at all developmental stages. The differences were greatest in premobile children. In this age group for children with unexplained bruising, it is essential that coagulation studies are done early to avoid the erroneous diagnosis of physical abuse when the child actually has a serious bleeding disorder, however a blood test compatible with a mild/moderate bleeding disorder cannot be assumed to be the cause of bruising.
Assuntos
Transtornos Herdados da Coagulação Sanguínea/complicações , Contusões/etiologia , Transtornos Herdados da Coagulação Sanguínea/epidemiologia , Transtornos Plaquetários/complicações , Transtornos Plaquetários/epidemiologia , Desenvolvimento Infantil , Pré-Escolar , Contusões/epidemiologia , Contusões/patologia , Feminino , Humanos , Lactente , Estudos Longitudinais , Masculino , Estudos Prospectivos , Índice de Gravidade de Doença , País de Gales/epidemiologia , CaminhadaRESUMO
The 50th Annual Scientific Meeting of the British Society for Haematology was notable, not only for its golden anniversary, but also because it coincided with the eruption of the Icelandic volcano, Eyjafjallajökull, and the ensuing travel chaos. In total, 28 speakers from overseas were unable to reach Edinburgh, including a significant number of British speakers who were stranded. However, owing to the superb efforts of the conference organisers and Edinburgh International Conference Centre staff, teleconferencing equipment was installed and all speakers were contacted and able to give their talks on time. The program, consisting of simultaneous sessions and plenary lectures, covered not only recent advances in clinical and laboratory hematology, but also reflected on the contribution of British hematology to the international arena over the past 50 years.
Assuntos
Doenças Hematológicas , Hematologia , Animais , Doenças Hematológicas/genética , Doenças Hematológicas/metabolismo , Doenças Hematológicas/terapia , Humanos , Sociedades Médicas , Reino UnidoRESUMO
The identification of specific chromosome abnormalities in acute myeloid leukemia (AML) is important for the stratification of patients into the appropriate treatment protocols. However, a significant proportion of diagnostic bone marrow karyotypes in AML is reported as normal by conventional cytogenetic analysis and it is suspected that these karyotypes may conceal the presence of diagnostically significant chromosome rearrangements. To address this question, we have developed a novel 12-color fluorescence in situ hybridization (FISH) assay for telomeric rearrangements (termed M-TEL), which uses an optimized set of chromosome-specific subtelomeric probes. We report here the application of the M-TEL assay to 69 AML cases with apparently normal karyotypes or an isolated trisomy. Of the 69 cases examined, 3 abnormalities were identified, all in the normal karyotype group. The first was a t(11;19)(q23;p13), identified in an infant with AML-M4. In 2 other young patients with AML (< 19 years), an apparently identical t(5;11)(q35;p15.5) was identified. Breakpoint mapping by FISH and reverse transcriptase polymerase chain reaction (RT-PCR) analysis confirmed that this was the same t(5;11) as previously identified in 3 children with AML, associated with del(5q) and resulting in the NUP98-NSD1 gene fusion. The t(5;11) was not detected by 24-color karyotyping using multiplex FISH (M-FISH), emphasizing the value of screening with subtelomeric probes for subtle translocations. This is the first report of the t(5;11)(q35;p15.5) in association with an apparently normal karyotype, and highlights this as a new, potentially clinically significant chromosome rearrangement in childhood AML.